A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer | |
Lu Yang; Yun Li; Arup Bhattacharya; Yuesheng Zhang | |
刊名 | Science Translational Medicine |
2019 | |
卷号 | Vol.11 No.476页码:eaav1620 |
ISSN号 | 1946-6234;1946-6242 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4736805 |
专题 | 湖南大学 |
作者单位 | 1.Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA 2.Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA 3.Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA. |
推荐引用方式 GB/T 7714 | Lu Yang,Yun Li,Arup Bhattacharya,et al. A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer[J]. Science Translational Medicine,2019,Vol.11 No.476:eaav1620. |
APA | Lu Yang,Yun Li,Arup Bhattacharya,&Yuesheng Zhang.(2019).A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer.Science Translational Medicine,Vol.11 No.476,eaav1620. |
MLA | Lu Yang,et al."A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer".Science Translational Medicine Vol.11 No.476(2019):eaav1620. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论